Summit Therapeutics shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Summit Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Summit Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Summit Therapeutics by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $6.0M | 334k | 17.85 |
| 2024-09-30 | $5.5M | 249k | 21.90 |
| 2024-06-30 | $2.2M | 280k | 7.80 |
| 2024-03-31 | $1.2M | 302k | 4.14 |
| 2023-12-31 | $894k | 343k | 2.61 |
| 2023-09-30 | $595k | 318k | 1.87 |
| 2023-06-30 | $799k | 318k | 2.51 |
| 2023-03-31 | $80k | 45k | 1.75 |
| 2022-12-31 | $90k | 21k | 4.25 |
| 2022-03-31 | $124k | 50k | 2.49 |
| 2021-12-31 | $135k | 50k | 2.72 |
| 2021-09-30 | $223k | 45k | 4.97 |
| 2021-06-30 | $276k | 37k | 7.43 |